Answers are grounded in this paper and cite their sources.
We compared the activity of norfloxacin (MK-0366), a new orally absorbable derivative of naladixic acid, with those of other antipseudomonal agents against Pseudomonas aeruginosa. Norfloxacin was the most active against both gentamicin-susceptible and gentamicin-resistant strains, having 90% minimal inhibitory concentrations of 2 and 8 micrograms/ml, respectively. This excellent in vitro activity may make norfloxacin effective for oral therapy of P. aeruginosa urinary tract infections.
No takes yet. Share an insight, caveat, or question.
Forward et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: